James Eshleman

James Eshleman

Johns Hopkins University

H-index: 76

North America-United States

About James Eshleman

James Eshleman, With an exceptional h-index of 76 and a recent h-index of 52 (since 2020), a distinguished researcher at Johns Hopkins University, specializes in the field of Pathology.

His recent articles reflect a diverse array of research interests and contributions to the field:

High-Grade, Nonsarcomatoid Chromophobe Renal Cell Carcinoma: A Series of 22 Cases With Novel Molecular Features on a Subset

CRISPR-cas9 genetic targeting of metastatic pancreatic cancer

Using Tumor Marker Gene Variants to Improve the Diagnostic Accuracy of DUPAN-2 and Carbohydrate Antigen 19-9 for Pancreatic Cancer

Using a CA19-9 Tumor Marker Gene Test to Assess Outcome After Pancreatic Cancer Surgery

Islands of genomic stability in the face of genetically unstable metastatic cancer

Genomic instability delays cell death in PDAC after simultaneous double strand breaks

Abstract LB_B02: Novel PAMs from somatic mutations produce numerous pancreatic cancer-specific CRISPR-Cas9 targets for selective cell elimination: A novel gene therapy approach …

MLH1 Loss in Primary Prostate Cancer

James Eshleman Information

University

Position

Professor of Patholgy Oncology

Citations(all)

58649

Citations(since 2020)

27238

Cited By

43739

hIndex(all)

76

hIndex(since 2020)

52

i10Index(all)

191

i10Index(since 2020)

139

Email

University Profile Page

Johns Hopkins University

Google Scholar

View Google Scholar Profile

James Eshleman Skills & Research Interests

Pathology

Top articles of James Eshleman

Title

Journal

Author(s)

Publication Date

High-Grade, Nonsarcomatoid Chromophobe Renal Cell Carcinoma: A Series of 22 Cases With Novel Molecular Features on a Subset

Modern Pathology

Ezra G Baraban

Roy Elias

Ming-Tseh Lin

Yasser Ged

Jing Zhu

...

2024/5/1

CRISPR-cas9 genetic targeting of metastatic pancreatic cancer

Cancer Research

Kirsten Bowland

Jiaying Lai

Selina Shiqing K Teh

Alexis Bennett

Alyza Skaist

...

2024/3/22

Using Tumor Marker Gene Variants to Improve the Diagnostic Accuracy of DUPAN-2 and Carbohydrate Antigen 19-9 for Pancreatic Cancer

Journal of Clinical Oncology

Yohei Ando

Mohamad Dbouk

Takeichi Yoshida

Helena Saba

Elizabeth Abou Diwan

...

2024/3

Using a CA19-9 Tumor Marker Gene Test to Assess Outcome After Pancreatic Cancer Surgery

Annals of Surgical Oncology

Yohei Ando

Mohamad Dbouk

Amanda L Blackford

Takeichi Yoshida

Helena Saba

...

2024/2/6

Islands of genomic stability in the face of genetically unstable metastatic cancer

bioRxiv

Kirsten Bowland

Jiaying Lai

Alyza Skaist

Yan Zhang

Selina Shiqing K Teh

...

2024

Genomic instability delays cell death in PDAC after simultaneous double strand breaks

Cancer Research

Selina Shiqing K Teh

Eitan Halper-Stromberg

Laura Morsberger

Kirsten Bowland

Alexis Bennett

...

2023/4/4

Abstract LB_B02: Novel PAMs from somatic mutations produce numerous pancreatic cancer-specific CRISPR-Cas9 targets for selective cell elimination: A novel gene therapy approach …

Molecular Cancer Therapeutics

Selina Shiqing K Teh

Kirsten Bowland

Alexis Bennett

Eitan Halper-Stromberg

Alyza Skaist

...

2023/12/1

MLH1 Loss in Primary Prostate Cancer

JCO precision oncology

Sanaz Nourmohammadi Abadchi

Laura A Sena

Emmanuel S Antonarakis

Colin C Pritchard

James R Eshleman

...

2023/5

Coincidence of InDels with missense mutations: 0, 1 or 2 artifacts

Cancer Research

Kelly E Craven

Catherine G Fischer

LiQun Jiang

Aparna Pallavajjala

Ming-Tseh Lin

...

2023/4/4

A highly sensitive pan-cancer test for microsatellite instability

The Journal of Molecular Diagnostics

Jeffery W Bacher

Eshwar B Udho

Ethan E Strauss

Irina Vyazunova

Steven Gallinger

...

2023/11/1

Morphology-guided transcriptomic analysis of human pancreatic cancer organoids reveals microenvironmental signals that enhance invasion

The Journal of clinical investigation

Yea Ji Jeong

Hildur Knutsdottir

Fatemeh Shojaeian

Michael G Lerner

Maria F Wissler

...

2023/4/17

IVT generation of guideRNAs for Cas9-enrichment nanopore sequencing

bioRxiv

Timothy Gilpatrick

Josh Zhiyong Wang

David Weiss

Alexis L Norris

James Eshleman

...

2023/2/7

Diagnostic Performance of a Tumor Marker Gene Test to Personalize Serum CA19–9 Reference Ranges

Clinical Cancer Research

Mohamad Dbouk

Toshiya Abe

Chiho Koi

Yohei Ando

Helena Saba

...

2023/10/13

Abstract LB357: CRISPR-Cas9 targeting of somatic mutations selectively kills cancer cells

Cancer Research

Kirsten Bowland

Selina Shiqing K Teh

Alyza Skaist

Ralph H Hruban

Nicholas J Roberts

...

2023/4/14

CRISPR-Cas9 for selective targeting of somatic mutations in pancreatic cancers

bioRxiv

Selina Shiqing K Teh

Kirsten Bowland

Alexis Bennett

Eitan Halper-Stromberg

Alyza Skaist

...

2023/1/1

Mechanism of delayed cell death following simultaneous CRISPR-Cas9 targeting in pancreatic cancers

bioRxiv

Selina Shiqing K Teh

Eitan Halper-Stromberg

Laura Morsberger

Alexis Bennett

Kirsten Bowland

...

2023/4/5

Colorectal cancer in patients of advanced age is associated with increased incidence of BRAF p. V600E mutation and mismatch repair deficiency

Frontiers in Oncology

Eric S Christenson

Hua-Ling Tsai

Dung T Le

Elizabeth M Jaffee

Jonathan Dudley

...

2023/6/7

Evaluation of long mononucleotide repeat markers for detection of microsatellite instability

Cancer Research

Suping Chen

John H Lin

Aparna Pallavajjala

Tamara L Lotan

Jeffery W Bacher

...

2023/4/4

Screening for pancreatic cancer has the potential to save lives, but is it practical?

Benjamin L Mazer

Jae W Lee

Nicholas J Roberts

Linda C Chu

Anne Marie Lennon

...

2023/6/3

Optimizing insertion and deletion detection using next-generation sequencing in the clinical laboratory

The Journal of Molecular Diagnostics

Kelly E Craven

Catherine G Fischer

LiQun Jiang

Aparna Pallavajjala

Ming-Tseh Lin

...

2022/12/1

See List of Professors in James Eshleman University(Johns Hopkins University)